BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9595647)

  • 1. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
    Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
    Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quality control in producing thrombocytapheresis preparations with minimal leukocyte contamination].
    Riggert J; Humpe A; Simson G; Köhler M
    Beitr Infusionsther Transfusionsmed; 1997; 34():89-94. PubMed ID: 9417356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; van Waeg G; Eckstein R
    Transfusion; 1997 Oct; 37(10):1045-9. PubMed ID: 9354823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
    Moog R
    J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of 3 leukocyte filters for thrombocyte concentrates].
    Reiser M; Kádár JG; Borberg H
    Beitr Infusionsther; 1991; 28():216-9. PubMed ID: 1725623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procedure for production of leukocyte depleted erythrocyte and thrombocyte concentrates (PRP method) using top and bottom bags, Optipress automated separators and a computer controlled Cryofuge 6000].
    Aulmann M; Ullrich R; Iber B; Neppert J
    Beitr Infusionsther; 1992; 30():122-6. PubMed ID: 1284686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing leukocyte-reduced platelets using the CS-3000 PLUS.
    Abreu ED; Strauss RG; Cordle DG; Kingery LR; Ludwig GA; Randels MJ
    J Clin Apher; 1996; 11(1):27-9. PubMed ID: 8722719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
    van der Meer PF; Vrielink H; Pietersz RN
    Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; Bunkens H; Eckstein R
    Transfusion; 2001 Mar; 41(3):396-400. PubMed ID: 11274597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of thrombocyte concentrates of the cell separator AS 104 with preparations of the cell separator CS 3000 (Fenwal)].
    Aulmann HM; Müller R; Zaky M; Avenarius HJ; Stangel W
    Beitr Infusionsther; 1990; 26():127-30. PubMed ID: 1703811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].
    Müller N; Krüssel H
    Beitr Infusionsther Transfusionsmed; 1994; 32():52-4. PubMed ID: 9480156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of cell separation with new single needle techniques in comparison with a current dual needle technique].
    Moog R; Müller N
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):86-90. PubMed ID: 8019114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods.
    Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Reesink HW
    Vox Sang; 2005 May; 88(4):275-7. PubMed ID: 15877650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new apheresis system for the collection of leukoreduced single-donor platelets.
    Zingsem J; Strasser E; Ringwald J; Zimmermann R; Weisbach V; Eckstein R
    Transfusion; 2007 Jun; 47(6):987-94. PubMed ID: 17524087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.